NMIBC Clinical Trials in Syracuse, New York
2 recruitingSyracuse, New York
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
NMIBC
ImmunityBio, Inc.40 enrolled9 locationsNCT06800963
Recruiting
Phase 2
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc.90 enrolled16 locationsNCT03945162